Cancer Research UK opens biopharm production unit
Cancer Research UK has established a £18m ($28.4m) biopharm manufacturing unit to produce complex experimental drugs, such as monoclonal antibodies.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs